ltemkr. The postoperative cardiac event rate was 89c for both sets. Pmgnostic accuracy (i.el WC area) wcs 71 + 3% (mean f SD) for the clinical and 81 2 3% for the clinical and dipyrklamole-thalliu models. Among the validation sets, areas were 74 f 9%, 72 2 7% aad 76 + 5% for each center. Observed and estimated rates were comparable for both seta. By the elinii modei, tbc observed rates were 34b, 8% and IS% for patients chaifled as low, moderate and bii risk by diil factors (p c Q.Wl). The addition of dipyrhkmml&hall+n data rectassiticd >SQ% of the moderate risk patients into low (3%) aod hii (19%) iiskca@ories(p<0.@001)butprovidednostxati6caWfor paticntsdassiiasloworkighEskaccord&tothcdinicalmodet.
Ciu&&is. Simple ciinical marBers, weighted accorxiii to prognostic impact, will reliably stratify risk in vascaku sorgery candidates referred for diiridamde-thalliu testin& thus sbvisting the need for the more expensive testing. Oar pAdiain model retains its progmstic accuracy when applied to the validatioa sets and can reliably estimate risk in this group. (J Am Cd Cordid 1996; 27:7'19-86) --concomitant coronary atherosclerosis (l-10). To reduce the incidence of perioperative cardiac events among vascular surgery candidates, clinicians have sought methods to stratify cardiac risk in individual patients. Patient management may thus be influenced by the patient's risk classification. For example, surgical treatment may be= deferred or ntodified to a less invasive therapy in high risk patients. Others, deemed to be at moderate risk of early events, may be further classified into more sperific risk categories by conducting diagnostic tests for the detection of coronary disease. Finally. low risk patients tight avoid further testing and undergo operation directly,, thus reducing cost, test-related morbidity and possible unnecessa? coronary angiography.
According to D&sky et al. (11.12) and Eagle and Boucher (13) , the first step in the assessment of risk is to consider the average risk of a major perioperative cardiac event amcng vascular surgery candidates. Factors such as referral patterns, general patient characteristics, surgical expertise and patient management will determine this level of risk for a particular mcdtcal institution. This v,duc, referred IO a% Ihc r\,mplication rate or. In Bayesian tctmc, rhc p&r p&&;.,~ may bc regarded as unique to a given mbtitution and a+ $uch rhould be supplied hy the clmrlan who w&s to compute a pam~Iti ;rrk esIima~r. Subuzqucmly. usin a &lye&an apptoach (t4), chtuclans should then petfotm "ta&" for each patient, which inch& gathering clinical daIa and conducting noninvasive stteu testing. The goal of these test5 is to tevise the prior ptobabiliry to a pnmcsr pobobifity that is mote representative of the patient's characteristics.
To Clinically teltvant dipytidamole-thallium results were described ar I) ischemic ECG changes. defined as a z I mm S'T scgmenl dcptession compared with baseline levels; I) planar myocatdial rintigtaphic images that on review by Iwo experienced observers showed fixed defects: and 3) images showing defecls that partially or completely redititributed on delayed (>3 h) imaging, Outcomr detemtinet!oa. At all ccntets, oulcomes were aswcsed by rr:dical record review and or intetview of th? treating physicians, the patients and their families. Outcomes of interest were nonfatal or fatal myocardial infarction or cardiac death. All patients were monitored by daily ECGs and serum cardiac enzyme levels (creatinine kinass-MB fraction
for 72 h after opetarion For the definition of myocardial infarction, Ihc University of Minnesota criteria were uwd: new lX'(i 0 wave h I mm or C'K-MB rl;%' or both. F;lIal cardiac events were defined as sudden death dire&y altrihutahle to myoccardial infarction, congestive failure or ventricular arrhythmia. All reported faatal events were confirmed by tcGew of ho#al records. autopsy (inding and dc;tIh cettiticatcs.
All tcporlcd non&al evenI,+ wc:tc' confirmed by medical tecurd rev& lot Ihe flC'G or snrymc ctiletia, or both. cilcd ptcviously.
Model devrlopmcnt. Two spccitied logistic regression models were developed using BMDP LR (BMDP Qatistical software. Inc.) !&ware:
clinical and dipytidamole-thallium vati-
I05 ( 0.01 t abies were regressed separately bccausc it was anticipated that in practice the models would be applied II) patient? who had not yet undergone dipyridamole-thallium testing and for whom these variables would be undefined. Appropriate interaction terms were also considered among the clinical variables, such as the possible interaction between advanced age and any of the cardiac or diabetic variables.
A Elayesian framework for the analysis permits the clinician to consider both the average risk (prior probability) and the patknt-specific predictive diagnostic information, which is referred to as the likelihood ratio (31). A likelihcmd ratio is typically computed for each clinical variable or test result from the proportion of patients with a particular result who cxpcrience an event divided by :he proportion who do not expericncc the event. Likelihood ratios >I yield a patient risk ertimatc greater than the average risk. Conversely. likelihtxti ratios iI imply that the patient's risk is below the average. One of the advantages to the use of likelihood ratios is that risk estimates can be revised sequentially, first by the likelihood ratios obtained for the set of clinical factors alone, then by the dipyridamole-thallium results if necessary. In this study, likelihood ratios were derived from logistic regression analyses using a previously described method (??-37).
Model vaNdalion.
Ultimately, any predictive model should be validated by comparing risk estimates to observed event Iates in both the challenge and validation sets Validation procedures arc typically rlesigncd to assc~ discrimination (3H) and calibration (39) pcrformancc.
c'olihru~ion rcfcrs to compa rability hL,,rccn obsctvcd and estimated rates. Di.wMmrion dePcribca u model'r ability IO separate a population into those who will experience the event and those who will not. Typically, "goodness of 61" tests (39) and receiver-operating charactcristic (ROC) curies (38) are used to evaluate a mod& calibration and discrimination, respectively.
Re!3ulta
Dlstrlbution of rlalt factora tacoding to outcome, The distributions of clinical and dipyrid~mole-thallium variables according to outcome is shown in Table I for perioperative events (all patients). There were 46 events (30 nonfatal, 16 fatal) among the 567 training set patient% (g%) and 39 events (27 nonfatal, I2 fatal) among 514 validation set patients (6%). With the exception of gender and perhaps advanced age, all clinical and all dipyridamole-thallium vuriabks in the training set were more prevalent among those patients with than without an event. l'hc computed udds ratios alss indicate a significant association between clinical and dipyridamolcthallium variablca and autcomc.
Thcrc iii also evidence of a protective effect among patients who underwent a priur corn nary bypa% proccdurc within 5 years. Three of the six clinical variables (prior myocardial infarction, diabetes, congestive heart failure) in the validation set were associated with events, and all dipyridamole-thallium variables were associated with outcome.
The major cardiac complication rates (nonfatal myocardial infarction, cardiac death) c!a&tcd according to type of vm lar surgical procedure arc shown in Table 2 for both the training and validation sets, These values thus correspond, to the procedure-specific prior probability of a cardiac event. Event rates in the training set were signifkzantly greater for infrainguinal(l3%, 95% cc,nfidencc interval [Cl] 8% to 18%) than for aortic (69,9S%
Cl 4% IO 8%) or carotid @b/r, 95% Cf I% to HI%,) procedures (p = 0.012). Again, event rates in the validation set were gredter for infrainguinal (ION 95% Cl 72 to 145 ) than aortic (6%. 95% Cl 2% to IZ%,) or carotid (6%. 9SCi. CI 3'% to 12%) prccedures, although these differences were not statistically significant. The logistic regrcssioc!ana&scs are detailed in of a f&operative cardiac eveat computed from a range of complication rates (prior probability) and the patient's clinical risk score. These estimates were calculated using logistic regression-derived likelihood ratios (32-37). Table 5 provides risk estimates obtained from the dipyridamolcthallium risk Kore. The prior probability for this model is defined as the posttest probability of the clinical model. The procedure required for estimating a patient-specific risk estimate from these tables is detailed in the Appendix.
Discussion
The present analysis expands on our earlier model (24) for predicting cardiac events by making use of a larger, more diverse population of vascular surgery c,ledidatcbs and limiting outcome dclinitioa to thr. " hard" end points of myocardial 3% vrrsus 3%. 17% vcrw3 14S;. 23% wxsus 26% and 4tt% versus 54%. The c&md and csumstcd risk for cacb risk tategop among the vrtidmtton set are 4% wrsw 3%, 0% "er3us l2&, !J% vcws 28% und 26% versus 42%. infarction or cardiac death, Furthcrmorc.
WC used an improved method of risk estimation that combines elements of Bayes theorem and logistic regression, yet requires no calculation beyond addition and subtraction of the risk estimate from Tables 4 and 5 . A clear advantage to this method is that it permits consideration of the procedure-specific institutional complication rate in the estimation of risk. Another advantage to the use of logistic regression to calculate likelihood ratios is [ha: it ic nnt necessary to assume independe ncc between those variables included in each mode) (31). The logistic regression method used here has been successfully applied elsewhere (32-37) and is one of several related methods of deriving likelihood ratios using logistic regrzsion (40) (41) (42) (43) . Logistic models have also been applictl previously in a sequential Bayesian manner (44) (45) (46) to estimate cardiac risk in general populations.
Dipyridamole-thallium testing provided further rehned risk strat;lication only among the patients classified as moderate risk (according to the clinical n~odcl): >&I% of these patients were reclassified as low or h&r risk. Thus, risk stratification according to the clinicat mod+ could reduce the need for further testing and may preverrt$he possible consequenccsof a false posithe result (unnmkry coronary angiography). Given the relatively high cost oti the thallium test, considerable savings are possible if its IW isi limited IU patients deemed to be at moderate risk according {o the dinical profile.
In contrast to our earlier studies (19,2,4), we noted diffcrences in the type of variables and the values of the coefiients found IO be independently predictive of cardiac risk. This is probably a result of the larger size of our cohort and the selection of the "hard" end points of ronfatal myocardial infArction or cardiac death versus the softer end points of cardiac ischrmic events (including unstable angina) used in c.ne of the earlier studies (24). The prognostic accuracy of the models, as expressed t"/ the ROC areas, is similar to values published elsewhere for patients un&rgoing noncardiac surgery: f&sky et al.
(1 I) reported a ROC area of HI ?. 4% for a multifactorial risk index, which is identical IO the value of 81 i: 3% obtained for our Dequrntial Lyesian models. Also, as shown in Figure 4 . risk stratification bs.sed on the clinical model alone could obviate the nerd for dipyridamole-thallium testing in nearly half the patients in this study. These patients could not be further stratified ard therefore did not benefit from added te,,ting in the operative setting.
valldatlosl asseMmeo ta. The validation assessments indicate some loss of prognostic~accuracy when the combined (clinical plus thallium) model v;as applied IO the validation set and some loss of reliability lo, tween observed and estimated events. For example. as shown in Figure 4 , the model lcttds to overestimitc risk when app)ir:d to the challenge set, partic& larly ut IL: higher risk levels i>20%).
However, the goodnem of tic p values indicate tha' overall the estimated risk does correspond lo the observe 1 rates for each of the vahition sets. Although ROC arez'are less for the validation set then the training .w!, there va).des indicate that good discrimination remains (Le., all areas .xcerd 50%) and rre superior to the external wlidation reults reported elsewhere for a similar model (13) . Such "st rinkage" may result from observed differences in the disttbution of risk facton behveen the event and nonevent grc.q.rs of patients between the training and validation sets (rahle I). However, it is reasonable to assume general compar,rbility between training and validation sets for the following canons: I) all centers included in the study are relatively lar;e urbsn [caching hospitals located in the northt astern Un:led States; 2) both the training and validation sets included ~uccessirc vascular $urgety candidates relend to the resp.ictive institution's cardiac nuclear laboratory for dipyridr~mole-thallium testing before major elective vascular surgeq ; 3) -6% of the training group and 6% of the validation set pa .ients were excluded because vascular surgery was post- Figure 4 demonstrates that a spectrum of clinical markers only, weighted according to prognostic impact, may significantly alter the prior probability of a pKtoperative cardiac event in a substantial number of patients rcferrcd for
The c!mician should first obtain an cstimale of the iMilitutionat periopc.ative rate of nonfatal myoc&al infarction or cardiac death for the rcquirecl vrrrulvr rurgcty proc~~Jurc, such as the valws listed in Table 2 . This ehtimatc is computed from the nunrber of eventsdivided by the total numhr of patients. For our exampk we will USE the dipyridamole-thallium testing, thus obviating the need for the more expensive cardiac screening. Also, the petijrmance of the clinical model indicates that it could be used by itself to estimate or stratify cardiac risk in patients not considered for further testing because of the urgency of the vascular procedure. However, it is also apparent from the thallium model that dipyridamole-thallium scanning reliably reclassifies a majority of intermediate risk patients
into low or high risk categories.
The prediction models d-i in this report retain much of their prognostic accuracy when applied to the validation Sets and can also reliably estimate risk in this group. The models arc thus generaltile to vascular surgery caudidirtes who prcscnt for clecl~e operdtion at major university rncdical CeMers.
p&operative cardiac complication rate for MXGC procedures, whii is 6%.
Second. the patient's II&CA record should be cunsulted to obtain mformrCon on all clinical variables Ii& at the bottom of Table 4 .
With this list, the patient's clinbl risk scorn is obtained by suntt~~ing lhe weights corresponding to ewh of 1he paliwl's clinical risk factor% For csample, if the patient wcrc a 6%yearutd candidale for aortic surgery with a hislory of dirbefcs and angina. the rbk score b
Cliniul ww = 0.X (Drahctes) + Il.8 L4ngina) = 1.6.
From Table 4 , rhe estimaled risk of a perioperative cardiac event that corr'sponds IO an institutional complicaGon rate of 6% and that falls within the clinical risk score range > I.5 to 2.0 is -13%. Thus. the "average" risk of a complication (6%) IS rxsrd VI .-13% for ati individudl patient who eahibh, the k,icn clin .: I isk factors Further risk discrimination basedon dlpriti* o&thallium resulta may be d&red it 1hc )laticnt wa$ rubseque~.1ly tes1ed and diiplaycd the L&nving results: positive ischcmic clectrocardiogr,rphic changes and a ---We ackmnulrdge ihc contributiuns of the follting 1~1 the developmenl of the validation data MS: From Yale tlnivcrrity, Stanley Rosenbaum, MD. Aan H. Nclwn, RN. Diwaker Jain, MD, Frans J. 'DI. Wackers. MD, Barry L. Caret MD; frum Deaconess Hospital. Steven E. Lane. MD. Stanley M. Lewis. MD, John 1. retenihle myocardial defect. The weights from thL d~oyridamotc-thallium model shown at the bottom of ' Table 5 corresponi:ag to these p :dictors are I ,2 and 1.3, respectively, L*r a total score of L.Z.
'Mlium score = I.? Ilschemic ST) + I 3 (Kc\cnihle defecll = 2.5.
